Drug Control Office Reauthorization: Boosting Naloxone Access and Fentanyl Enforcement.
This Act reauthorizes the federal Office of National Drug Control Policy (ONDCP) until 2031, focusing heavily on life-saving measures and combating fentanyl. It mandates increased availability of naloxone (overdose reversal agents) for first responders and communities, while allocating specific funds and prosecutorial resources to target fentanyl traffickers. Citizens benefit from enhanced public health tools and greater government transparency regarding drug control data and surveillance programs.
Key points
Mandates increased accessibility of life-saving overdose reversal agents, such as naloxone, for local communities and emergency services.
Allocates dedicated funding (minimum $5 million annually) and prosecutorial resources to enhance the seizure and interdiction of fentanyl and target trafficking organizations.
Extends funding and increases maximum grants for local anti-drug coalitions and community prevention programs through 2031.
Requires regular public reporting on data analytical programs (like Hemisphere) to ensure activities comply with Fourth Amendment protections against unreasonable search.
100%
VOTING RESULTS
2024-12-05
For
399
Against
1
Abstain
0
Status:
Expired
Record your position for audit.
Why does your vote on bills matter?
It creates raw, undeniable proof. Civic Will provides the permanent data to verify the Government's loyalty towards its citizens
(explained here).
Start recording it now.